InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: EichKing post# 11311

Thursday, 03/22/2018 10:16:50 AM

Thursday, March 22, 2018 10:16:50 AM

Post# of 44784
See EichKing. NEVER any discussion. Everything is great. We are years ahead of everyone and competition is irrelevant with our lightning speed progression. Our IC trial, was originally thought to be competed the end of 2015. But our CLI trial will fly by.

But Celularity has no idea what they're doing. Only our placenta cells work because we are the best. Good results in their diabetic foot ulcer study couldn't open the door for CLI could it, considering they're looking at similar secondary measures could they. Fast track, accelerated approval, breakthrough designation, compassionate use..all just designed for us. No way they could leap right over us in CLI, all while we try and enrol the first half and then just wait to hear.

And have a look yourself at any indication we have. You know, the ones with some good rodent results. Nobody is ahead of us there. We have orphan drug status!!! Untouchable!!! Only one without much competition is muscle injury following hip surgery. Wonder why?

Management has a good track record of making their estimates right. Our IC trial was supposed to get results the end of 2015 originally. But what's a couple of years in reality. We are light years ahead remember. And we have the right people to ensure we come out on top. End of discussion, for the bitten ones. Especially one post wonder.

And here you go...we'll get em next week. We have all the time in the world.